• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Mogroside V

Mogroside V

Product ID M568270
Cas No. 88901-36-4
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $120.00 In stock
25 mg $343.00 In stock
100 mg $1,052.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Mogroside V is a triterpenoid isolated from the traditional Chinese medicinal plant Siraitia grosvenorii. Because of its intense sweetness, mogroside V is commonly used as a natural sweetener. It inhibits pancreatic tumor growth in in vitro and in vivo tumor models. It promotes apoptosis and cell cycle arrest of pancreatic cancer cells (pANC-1 cells). It was also found to inhibit angiogenesis and reduce vascular density in tumor growth. It has potent anti-inflammatory activity by inhibiting LPS-induced COX-2 expression/ROS production and overexpression of HO-1 by blocking phosphorylationofKT1 I RAW264.7 cells.

Product Info

Cas No.

88901-36-4

Purity

≥98%

Formula

C60H102O29

Formula Wt.

1287.4

Chemical Name

Mogrol-3-O-(beta-D-glucopyranosyl (1-6)-beta-D-glucopyranoside)-24-O-((beta-D-glucopyranosyl (1-2))-(beta-D-glucopyranosyl(1-6))-beta-D-glucopyranoside)

IUPAC Name

(2R,3R,4S,5S,6R)-2-[[(2R,3S,4S,5R,6R)-6-[[(3S,8S,9R,10R,11R,13R,14S,17R)-17-[(2R,5R)-5-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-6-hydroxy-6-methylheptan-2-yl]-11-hydroxy-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

Synonym

Mogrol-3-O-(beta-D-glucopyranosyl (1-6)-beta-D-glucopyranoside)-24-O-((beta-D-glucopyranosyl (1-2))-(beta-D-glucopyranosyl(1-6))-beta-D-glucopyranoside); mogroside-V

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

M568270 MSDS PDF

Info Sheet

M568270 Info Sheet PDF

References

C Liu, L-H Dai, D-Q Dou., et al. A natural food sweetener with anti-pancreatic cancer properties. Oncogenesis. 2016, 5(4). PMID: 27065453 DOI: 10.1038/oncsis.2016.28.

Yong Li, Luyan Zou, Tao Li. et.al. Mogroside V inhibits LPS-induced COX-2 expression/ROS production and overexpression of HO-1 by blocking phosphorylation of AKT1 in RAW264.7 cells. Acta Biochim Biophys Sin (Shanghai). 2019 ;51(4):365-374. PMID: 30877761 DOI:10.1093/abbs/gmz014.

Xiao R, Liao W, Luo G, et al. Modulation of gut microbiota composition and short-chain fatty acid synthesis by mogroside V in an in vitro incubation system. ACS Omega. 2021 Sep 21;6(39):25486-25496. PMID: 34632206.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • G1721

    Gefitinib

    EGFR inhibitor.

    ≥98%
  • C4646

    Clofarabine

    Nucleoside (adenosine) analog; DNA chain termin...

    ≥98%
  • A5035

    5-Aminosalicylic Acid

    Salicylic acid derivative; PPARγ agonist, pote...

    ≥98%
  • N3278

    7-Nitroindazole

    nNOS inhibitor.

    ≥98%
  • A7200

    AS-252424

    p110γ PI3K inhibitor, potential TRPC1/5/6 nega...

    ≥98%
  • F4881

    Flumequine Sodium

    Fluoroquinolone; bacterial DNA gyrase inhibitor...

    ≥98%
  • E5477

    Entinostat

    Benzamide; HDAC1 inhibitor.

    ≥98%
  • D5709

    Docetaxel

    Semi-synthetic analog of taxol; microtubule dep...

    ≥98%
  • U698576

    Urolithin B

    Ellagic acid derivative produced by gut microfl...

    ≥99%
  • T6811

    Tranexamic Acid

    Plasminogen inhibitor.

    ≥98%
  • K040009

    KB-0742 dihydrochloride

    CDK9 inhibitor.

    ≥99%
  • P8382

    Puupehenone

    Sesquiterpene found in marine sponges.

    ≥94%
  • T6803

    Trandolapril

    ACE inhibitor.

    ≥98%
  • B5072

    BMS-754807

    InsR and IGF-1R inhibitor.

    ≥99%
  • H1894

    Hexestrol

    Synthetic catechol; ER agonist, microtubule pol...

    ≥98%
  • D022705

    Darunavir

    HIV and AIDS

    ≥99%
  • N7200

    NS-11394

    GABA-A α5/3/2 positive modulator.

    ≥98%
  • R3577

    Ritonavir

    HIV protease inhibitor.

    ≥98%
  • P0093

    Paclitaxel, semi-synthetic

    Semi-synthetic diterpene originally found in Ta...

    ≥99%
  • B6802

    Bradykinin (1-3)

    Natriuretic, vasodilatory peptide fragment; B1/...

    ≥95%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only